e-Profile Login and ID Quick Search
News tagged narrow-therapeutic-index
DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions
Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances that are missing information required by law, Drug Enforcement Administration provides guidance for pharmacists regarding allowed changes or additions to such prescriptions.
Read More →Nominations for 2014 NABP Annual Awards Now Being Accepted
NABP invites you to nominate a colleague or board of pharmacy for a 2014 NABP award.
Read More →North Carolina News: Item 2121 - Medicare Part D Plans and NTI Drugs
Reprinted from the July 2006 North Carolina Board of Pharmacy Newsletter. The Board has received several complaints that Medicare Part D payors are refusing to reimburse pharmacists for dispensing one particular generic version of a Narrow Therapeutic Index (NTI) drug...
Read More →